Dominik Bernhagen Ph.D.

Dr. Dominik Bernhagen has a diverse work experience, with their most recent role being the Director Sales Europe at AmbioPharm. At AmbioPharm, they are responsible for overseeing sales operations in Europe and promoting the company's expertise in developing manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs). Prior to AmbioPharm, they worked as a Key Account Manager at Senn Chemicals AG from 2018 to 2021. Dominik also gained experience as a PhD Student/Junior Scientist at Pepscan from 2015 to 2018. Additionally, Dr. Bernhagen has worked as a Guest Scientist at various institutions such as Radboud University Nijmegen, The Netherlands Cancer Institute, TPNBT - Technical Proteins Nanobiotechnology, and DWI - Leibniz-Institut für Interaktive Materialien. Dominik started their career as a Scientific Assistant at TU Dortmund University in 2013.

Dominik Bernhagen Ph.D. obtained their Bachelor of Science (B.Sc.) degree in Chemistry from TU Dortmund University, where they studied from 2009 to 2012. Dominik then pursued a Master of Science (M.Sc.) degree in Chemistry at the same institution from 2012 to 2014. Following this, they attended RWTH Aachen University from 2015 to 2019, where they earned their Doctor of Philosophy (Ph.D.) in Peptide Chemistry / Biomaterials.

Additionally, Dominik Bernhagen Ph.D. has acquired additional certifications, including "New in Leadership" from KV Business School Zürich in December 2022 and "Principles of Biochemistry" from Harvard University. Dominik also completed a certification in "Project Management: Mastering Complexity" from Delft University of Technology and a certification in "Sales" from TRAINING GUSTAV KAESER INTERNATIONAL, although the specific months and years of obtaining these certifications are not provided.